Seqirus opens U.K. office; Mitsubishi Tanabe plans U.S. flu vaccine;

> CSL's flu vaccine unit Seqirus opened a U.K. corporate office. Release

> Japan's Mitsubishi Tanabe Pharma plans to focus on increasing its U.S. sales, with one component of its strategy involving a flu vaccine currently under development. Report

> A paper in PLOS Medicine argues in favor of a compensation system for vaccine injuries for cases such as the Ebola outbreak in which vaccines must be tested rapidly without hesitation due to liability. More

Suggested Articles

As of Friday after local time, 36 people have died in Korea after getting flu shots provided by at least seven companies, including Sanofi.

As COVID-19 vaccines advance, the FDA held an expert hearing Thursday to talk safety, efficacy, distribution plans and vaccine confidence—plus more. 

Moderna, racing ahead with COVID-19 vaccine R&D, completed enrollment for its late-stage trial—and moved one step closer to approval.